Has Nike Hit Bottom, or Is $33 Just a Pit Stop Lower?

NEW YORK — Nike closed Friday at $33.87, a price the stock last visited in 2013 — a number that tells you almost everything you need to know about what one earnings report, one guidance cut, and one very bad week can do to a brand that once seemed immune to gravity.

A Brand Built on Scale, Now Fighting for Relevance

Nike is the world’s largest athletic footwear and apparel company by revenue, operating across North America, Europe, the Middle East and Africa, Greater China, and Asia Pacific. Its investor relations page frames a company built on direct-to-consumer expansion, premium product positioning, and global brand licensing — a model that generated roughly $51 billion in annual revenue at its peak.

The strategic pivot that defined the last three years was a deliberate pullback from wholesale channels to prioritize Nike’s own digital and retail ecosystems. That bet looked smart when consumer spending was strong. It looks considerably more exposed when demand softens across every major geography simultaneously. CEO Elliott Hill, who returned to lead the company after Phil Knight’s handpicked successor departed, has layered a restructuring plan — branded the Pace program — on top of an already weakened demand environment. The company confirmed this week that additional layoffs are coming as part of that effort.

Competitors including On Running and Hoka have gained meaningful share in the premium performance segment, while Adidas has stabilized faster than many analysts expected after its own crisis. Nike’s brand moat is real. The question is how wide it remains after two years of market share erosion. As we covered earlier this week in our broader market context piece, Nike’s 8% single-session plunge was the most dramatic consumer-sector move of the week.

The Numbers Tell a Harsher Story Than the Headline EPS

Surface-level, Nike’s Q1 FY2027 results appeared mixed: EPS of $0.48 beat the $0.43 consensus by $0.05. But revenue of $11.21 billion missed the $11.32 billion estimate by $110 million, declining 4.2% year-over-year on a reported basis and 5% on a currency-neutral basis.

Greater China was the most alarming line item. Revenue in that segment fell 22% year-over-year — a figure that reflects not just macro pressure but competitive displacement by domestic Chinese brands including Anta and Li-Ning. EMEA also declined. North America, historically Nike’s most resilient market, showed no meaningful offset.

Data Visual

Nike Analyst Price Targets After Q1 FY2027 Earnings (Oct 2, 2026)

Shows the revised price targets from eight major banks following Nike’s earnings report, revealing how far below the consensus each firm now sits.

Values in $

The valuation picture is genuinely complicated. Nike’s trailing P/E of 16.23 sits just above the footwear and accessories sector weighted average of 15.38x, according to sector comparative data. The EV/EBITDA of 11.46x looks reasonable in isolation. But those multiples are calculated on trailing earnings. On the forward guidance Nike just provided — a midpoint EPS of $1.25 against a $33.87 price — the stock trades at roughly 27x forward earnings. That is not a cheap stock in a declining revenue environment. The sector’s 3-year average P/E of 27.4x provides a loose ceiling, not a floor of support.

The 4.84% dividend yield will attract income-focused investors, and it should. But sustainability questions arise if EBIT declines even faster than revenue — which is exactly what management guided. Nike said EBIT would decrease more sharply than the high single-digit revenue decline it projected for FY2027. That is a margin compression warning, and it has direct implications for free cash flow available to sustain the dividend.

Data Visual

Nike NKE Share Price: 52-Week Range vs. Key Valuation Levels

Plots Nike’s 52-week high, consensus analyst target, current price, 52-week low, and Bank of America bear-case target to show where the stock sits relative to the range of outcomes traders must price.

Values in $

Eight Banks, Eight Target Cuts, Zero Consensus on the Floor

The analyst response to Nike’s earnings was swift and largely uniform in direction, if not in magnitude. Eight firms revised their price targets lower in a single session on October 2, creating an unusually wide range of outcomes that itself signals deep disagreement about where Nike’s earnings power stabilizes.

The full picture from this week’s rating activity: Goldman Sachs moved to Neutral at $30. Morgan Stanley held Underweight at $27. Citigroup set Neutral at $32. Bank of America’s $24 target implies 29% further downside from Friday’s close. Wells Fargo’s Ike Boruchow maintained Equal-Weight but slashed the target 25% to $30. Baird held Neutral at $36. Williams Trading downgraded to Hold at $30. BTIG stood apart, maintaining Buy at $50 — a target that now sits 48% above the current price and represents the most bullish case on the Street.

The consensus, per MarketBeat aggregation, is now 1 Strong Buy, 9 Buy, 22 Hold, and 7 Sell, with an average target of $42.12. That average target is almost certainly stale — it reflects ratings not yet updated post-earnings. The post-earnings targets cluster between $24 and $50. The real working consensus among those who just revised is closer to $29–$32.

This kind of analyst dispersion — a $26 spread between the lowest and highest post-earnings targets — is not a sign of healthy uncertainty. It reflects genuine disagreement about whether Nike’s earnings power is $1.25 per share or something materially higher once the restructuring cycle completes. That debate will not be settled by one more quarter. For broader context on how this earnings season is reshaping market expectations, see our piece on whether the market is ready for earnings to carry the tape.

What Has to Happen for the Thesis to Change

The path back for Nike is not complicated to describe. It is very hard to execute. Greater China needs to stabilize — not recover to prior peaks, but stop contracting at 20%-plus rates. The direct-to-consumer channel needs to demonstrate that pulling back from wholesale did not permanently cede shelf space to rivals who will not return it. And the Pace restructuring program needs to show that cost savings are flowing to the bottom line faster than revenue declines are eroding it.

None of those conditions are visible in the current data. What is visible is a stock trading at a 13-year price low, a market cap that has fallen from over $160 billion at its 2021 peak to $50.24 billion today, and management guidance that implies the worst of the revenue decline has not yet been reported. The Q2 FY2027 print — expected in early January 2027 — will be the first real test of whether the guidance reset was conservative or accurate.

The guidance shock Nike delivered this week echoes patterns seen in other restructuring stories this earnings season. As we noted in our analysis of Synopsys’s FY2027 guidance shock, markets increasingly punish companies that use forward guidance to manage expectations downward over multiple quarters rather than resetting once and moving on. Nike’s credibility with the Street depends on whether this guidance proves to be the floor.

There is one counterargument worth taking seriously: at $33.87 with a 4.84% dividend yield and an EV/EBITDA of 11.46x, Nike is not priced for a recovery. It is priced for continued decline. If management has in fact set a conservative baseline — and corporate guidance in restructuring periods often skews pessimistic — the risk-reward calculates very differently for a two-year holding period than it does for the next two quarters. That possibility is what keeps BTIG at Buy and keeps the average target above $40 despite the carnage.

The Levels That Define the Next Move

Nike enters Monday as a stock with a clear bearish consensus, a credible bull counterargument, and no near-term catalyst that resolves the debate cleanly. The 52-week low at $31.97 is the line that matters most for short-term traders. Below it, the stock has no recent technical support until levels not seen since 2012. Above it — and specifically above the $35–$38 range where most revised targets cluster at the low end — the burden of proof shifts to management to demonstrate the guidance reset was the bottom, not the beginning. Neither outcome is certain. What is certain is that at $33.87, the market is pricing Nike as a company in structural decline, not temporary disruption. The January earnings report will be the first real verdict on whether that judgment is correct.